Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a revision label of v3.5.4, replacing the previous v3.5.3 in the Record History. This reflects a minor update to the page's revision metadata.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision label has been updated from v3.5.2 to v3.5.3, indicating a new software release. No study-specific details on the record history table appear to be changed.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision history updated: a new entry Revision: v3.5.2 was added, and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision v3.5.0 has been added and v3.4.3 removed in the study record history.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision history now includes v3.4.3 and removes v3.4.2.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision entry, v3.4.2, was added to the study record history; a government-funding operating-status notice and the prior revision note v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.